Prognosis of Patients With Ischemic Stroke With Prior Anticoagulant Therapy: Direct Oral Anticoagulants Versus Warfarin
Our study confirmed that DOACs have a better prognosis than warfarin after ischemic stroke. The apixaban and edoxaban groups had a lower risk of death after ischemic stroke than the other DOAC groups.
Authors
- Jung Hwa Hong
- Kyeong‐Hyeon Chun (ORCID: https://orcid.org/0000-0002-7798-658X)
- Kwon–Duk Seo (ORCID: https://orcid.org/0000-0003-3154-8864)
- Hancheol Lee (ORCID: https://orcid.org/0000-0003-2400-3487)
Institutions
- Kangwon National University (KR)
- National Health Insurance Service Ilsan Hospital (KR)
- National Health Insurance Service (KR)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1161/jaha.124.034698
- Citations
- 5
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01